The overall purpose of this study is to evaluate the analgesic efficacy of liposomal
bupivacaine in optimizing pain control, minimizing the risk of postoperative nausea and
vomiting (PONV), and improving recovery after abdominoplasty. This will be done by comparing
intraoperative abdominal wall and incisional injection of bupivacaine to bupivacaine plus
liposomal bupivacaine in 46 participants 18 years and older undergoing elective
abdominoplasty. This will be studied using pain assessments, validated surveys, medication
logs and review of medical records.